Regulatory Affairs and Drug Approval

Regulatory Affairs and Drug Approval focuses on the processes and policies governing the development, evaluation, and authorization of pharmaceuticals. This track will explore global regulatory frameworks, submission requirements, and approval pathways across major agencies like FDA, EMA, and others. Topics include compliance, clinical trial regulations, documentation standards, and post-marketing surveillance. Emphasis will be placed on aligning scientific innovation with regulatory expectations to ensure the timely delivery of safe, effective, and high-quality medicines to patients.

 

    Related Conference of Regulatory Affairs and Drug Approval

    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France

    Regulatory Affairs and Drug Approval Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in